JPRN-UMIN000001038
Completed
Phase 1
Multicenter phase I/II trial of adjuvant combination chemotherapy with gemcitabine and S-1 for pancreatic cancer - Phase I/II trial of adjuvant chemotherapy with gemcitabine and TS-1 for pancreatic cancer
Study Group for Adjuvant Chemotherapy of Pancreatic Cancer0 sites55 target enrollmentApril 1, 2008
Conditionspancreatic cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- pancreatic cancer
- Sponsor
- Study Group for Adjuvant Chemotherapy of Pancreatic Cancer
- Enrollment
- 55
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Watery diarrhea 2\)Severe mental disorder 3\)Active infection 4\)Severe complications, such as ileus, heart failure and renal failure 5\)Symptomatic pulmonary fibrosis or interstitial pneumonia 6\)History of radiation therapy to the chest 7\)Marked pleural or peritoneal effusion 8\)Active concomitant malignancy 9\)Treatment with phenytoin, potassium warfarin or flucytosine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A Phase I/II Trial of combined adjuvant therapy with gemcitabine and cisplatin for resected biliary tract cancerResected biliary tract cancerJPRN-UMIN000004359Shinshu University School of Medicine, Surgery33
Recruiting
Phase 1
A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma.glioblastomaMedDRA version: 20.0Level: PTClassification code: 10018337Term: Glioblastoma multiforme Class: 100000004864MedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2023-508278-26-01Z Brussel18
Completed
Phase 2
Phase II trial of neoadjuvant combination chemotherapy with gemcitabine and S-1 for locally advanced pancreatic cancerlocally advanced pancreatic cancerJPRN-UMIN000001450Faculty of Medicine, Kyoto University35
Recruiting
Phase 2
Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.Hepatocellular CarcinomaNarrow MarginRadiotherapyNCT06205472Cancer Institute and Hospital, Chinese Academy of Medical Sciences100
Recruiting
Phase 2
Phase II trial exploring combined neoadjuvant therapy with Pembrolizumab/Lenvatinib and adjuvant Pembrolizumab in patients with surgically resectable Non-Small- Cell Lung Cancer (NSCLC)2024-514821-45-00Medizinische Universitaet Innsbruck33